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Ming Zhu1, Jun Li2*, Ke-Jing Wang1 and Jin-Biao Shang1Abstract
We report five cases of primary synovial sarcomas arising in the parapharyngeal space. The patients were all men
with a median age of 35 years (range 22 to 41 years). The tumors were non-encapsulated solid masses ranging from
2.0 to 6.6 cm in size. Histologically, three cases were biphasic subtype, and the other two cases were monophasic
subtype. Immunohistochemically, the tumor cells were strongly positive for bcl-2 and CD99, partly positive for CK
and EMA, and negative for CD117, CD34, SMA and desmin in all five cases. S-100 protein was detected in one case.
The presence of an SYT–SSX1 and/or SYT-SSX2 gene fusion resulting from t(X;18) was demonstrated from paraffin
blocks by reverse transcriptase polymerase chain reaction in five cases. All five patients received tumor radical
excision and postoperative radiotherapy, and two patients with pulmonary metastasis received additional
chemotherapy. Follow-up data revealed that two patients with tumor size <5 cm were alive without disease for 54
and 57months, one patient with tumor size <5 cm was alive with pulmonary metastasis for 78 months, and two
patients with tumor size >5 cm died of disease 26 and 37months after the diagnosis, respectively. Primary
parapharyngeal synovial sarcoma is a rare variant that occurs more frequently in males than females. Accurate
diagnosis depends on morphologic and immunohistochemical examination and proper molecular analysis. The
prognosis is relatively good in those patients whose tumor size is less than 5 cm.
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Prognostic factorsBackground
Parapharyngeal space (PPS) tumors comprise approxi-
mately 0.5% of head and neck tumors [1]. Synovial sar-
coma (SS) of the head and neck is rare, accounting for
only less than 10% of all head and neck soft tissue sarco-
mas [2]. Very few reports of primary parapharyngeal syn-
ovial sarcoma (PPSS) have been published, and most of
these reports have been based on histological and im-
munocytochemical examination. In this study, we describe
five cases of PPSS diagnosed with the assistance of histo-
logical,immunocytochemistry and molecular pathology.
Case presentation
Among this group, four cases of PPSS were from Zhejiang
Cancer Hospital and the other was from the First Affiliated
Hospital, College of Medicine, Zhejiang University.* Correspondence: lijunfee@yahoo.com.cn
2Department of Pathology, The First Affiliated Hospital, College of Medicine,
Zhejiang University, Hangzhou 310003, Peoples Republic of China
Full list of author information is available at the end of the article
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Commons Attribution License (http://creativec
reproduction in any medium, provided the orAll five patients were men with a median age of 35 years
(range 22 to 41 years). On physical examination there was
a mass arising from the intraoral, neck or pharyngeal space
in five patients causing dysphagia (two of five) and pain
(one of five) for 1 to 12months. No patients had a previous
history of sarcoma or radiation at the tumor site.
Although fine needle aspiration biopsy (FNA) biopsies
were performed in two patients, pathologists interpreted
these cytological specimens as a parotid carcinoma or
neurogenic neoplasm. In one patient, an intraoral open bi-
opsy was carried out and achieved correct diagnosis of
PPSS.
All five patients were treated with surgical extirpation of
the tumor. Transcervical and transmandibular approaches
were performed in four patients and one patient, respect-
ively. Complete gross examination was available for all five
tumors, and the surgical margins were all negative in the
excision specimens. No lymph node metastases in the sur-
gical specimen of regional or total neck were found in two
patients.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 CT scan showing a 3.0-cm mass of the parapharyngeal
space in Case 2.
Figure 3 Case 1: the tumor had a monophasic appearance
composed of spindle cells forming interlacing fascicles
(H&E, 20×).
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http://www.wjso.com/content/10/1/158Macroscopically, the tumors were gray-white, elastic-
ally soft, areas of necrosis and hemorrhaging, non-
encapsulated solid masses, ranging in size from 2.0 to
6.6 cm (Figure 1). Histologically, the tumor in three cases
presented a biphasic subtype composed of spindle-shaped
cells and epithelial cells (Figure 2). Architectural forma-
tions characteristic of epithelial differentiation, including
acinar-like structures, tubules (glands) and flat sheets, all
dissociated from spindle cells. The other two cases had a
monophasic appearance, composed mainly of uniform
spindle cells forming interlacing fascicles (Figure 3). Por-
tions of the tumor showed a hemangiopericytomatousFigure 2 Histological feature revealed biphasic pattern
composed of spindle-shaped cells and glandular spaces in
Case 3 (H&E, 20×).pattern consisting of polygonalcells arranged around
dilated, thin-walled blood vessels. By immunohistochemis-
try, both epithelial and spindle tumor cells were strongly
positive for bcl-2 and CD99, and the spindle cells were dif-
fusely expressed vimentin (Figure 4) in all five cases. CK
and EMA were partly positive in the spindle cells and dif-
fusely positive in the glandular part (Figure 5) of three bi-
phasic cases, as well as focally positive in the spindle cells
of the other two monophasic cases. S-100 protein was fo-
cally positive in one monophasic case. The tumor cells of
the five cases were negative for SMA, desmin, CD117 and
CD34.
We performed the molecular genetic examination by a
reverse-transcriptase polymerase chain reaction assay (RT-
PCR) that detects (the paraffin blocks, formalin-fixedFigure 4 By immunohistochemistry, the tumor cells of Case 5
were strongly positive for vimentin (DAB, 20×).
Figure 5 Case 4: CK was positive in the spindle cells and the
glandular part (DAB, 20×).
Figure 6 SYT-SSX gene fusion was found in all five cases
by RT-PCR. The amplified fragments were identified by their size
(87 bp) on DNA electrophoresis using 1.5% agarose gel. (−, negative
control; +, positive control).
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from t(X; 18), the characteristic phenotype of SS. The pri-
mers chosen detected both of the SSX1 and SSX2 partners,
and the target sequence was 87 base pairs (bp) [3]. The
presence of an SYT–SSX gene fusion was demonstrated
from the paraffin blocks of all five cases by RT-PCR. The
amplified fragments of the positive control and our cases
were identified by their size (87 bp) on DNA electrophor-
esis using 1.5% agarose gel (Figure 6). Both pathologic and
molecular examination confirmed the diagnosis of PPSS of
the five cases.
Postoperative complications were found in three
patients: two cases appeared with temporary neuropathies
of the marginal mandibular branch of the facial nerve and
one patient developed problems with malocclusion.
All five patients received postoperative radiotherapy
(50 to 70Gy), and two patients with pulmonary metasta-
sis received additional chemotherapy, including doxo-
rubicin (50mg/m2) and ifosfamide (7.5 g/m2).
At follow-up in May 2012, three patients had a tumor
less than 5 cm: two patients were alive without a tumor
for 54 and 57months after surgery, respectively; and one
patient with pulmonary metastasis received seven peri-
ods of chemotherapy and was still alive with a tumor for
78months. Two patients with a tumor size larger than
5 cm died of the disease 26 and 37months after the op-
eration, respectively, because of local recurrence and
multiple pulmonary metastatic foci.
Clinicopathological features of the five cases of PPSS
are shown in Table 1.
Discussion
Neoplasms arising from the PPS are uncommon and ac-
count for only 0.5% of all tumors that occur in the head
and neck region. Reports in the literature indicate that70 to 80% of the parapharyngeal tumors are benign and
20 to 30% are malignant [1]. Benign neurogenic and sal-
ivary gland neoplasms, such as pleomorphic adenoma,
are the most common tumors. SS of the head and neck
region are rare with less than 150 cases reported in the
international literature, and PPSS is an extremely rare
variant with scattered reports. Research reveals that SS
originates from primitive mesenchyma with no synovial
association in the PPS [4]. In the current study, we re-
port five additional cases.
There are no specific features of PPSS in the clinical
manifestations and the imaging modalities. Patients usu-
ally present a painless slow growing mass during their
third and fourth decade of life with associated compres-
sive or infiltrative symptom of surrounding structures,
and males tend to be affected more often than females
[5]. Consistent with the literature, our five patients
were all men and their median age was 35 years (range
22 to 41 years). Four of the five patients presented a
painless mass, and two of the five patients appeared
dysphagic.
Microscopically, the classic forms of the SS have bi-
phasic and monophasic patterns. When the biphasic
Table 1 Clinicopathologic features of five cases of PPSS
Case Age Tumor size LN Subtype Treatment Outcome Survival
1 28 3.5 × 2.2 cm2 N monophasic Excision + rad + chemo ATPM 78m
2 41 2.9 × 2.7 cm2 N biphasic Excision + rad ANED 57m
3 22 4.0 × 3.1 cm2 0/8 biphasic Excision + rad ANED 53m
4 31 5.2 × 4.9 cm2 0/21 biphasic Excision + rad + chemo DOR 26m
5 37 6.6 × 5.1 cm2 N monophasic Excision + rad DOPM 37m
ANED alive with no evidence of disease, ATPM alive with pulmonary metastasis, DOPM died of pulmonary metastasis, DOR died of tumorous recurrence,
LN indicates lymph node metastases, mmonths, N no check.
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diagnosis of SS may be possible. Monophasic fibrous SS,
which is the most common subtype of SS, is very chal-
lenging to diagnose on histology. Therefore, immunohis-
tological staining was significant in the differential
diagnosis of SS from other sarcomas [6]. The tumor cells
were positive for CD99, bcl-2 and focally reactive for
CK, EMA in all five cases. S-100 protein was focally
positive in one case. The nonreactivity of the tumor for
SMA, desmin, CD34 and CD117 in our five cases argues
against the diagnoses of leiomyosarcoma, rhabdomyosar-
coma, solitary fibrous tumor and gastrointestinal stromal
tumor [7]. Although malignant peripheral nerve sheath
tumor is another sarcoma that usually occurs in the
PPS, this tumor’s cells tends to show much greater aty-
pia and S-100 protein immunohistochemical reactivity is
more frequent than that seen in SS. In contrast, the CK
positivity is more limited than that of SS.
The definitive diagnosis of SS should be made by mo-
lecular analysis, even more when the tumor arises in an
unusual location, such as the PPS. Ninety percent of
head and neck SS contains a specific translocation be-
tween chromosome X and 18, t(x; 18)(p11.2;q11.2) [2],
that result in the presence of an SYT-SSX1, SYT-SSX2
and rarely SYT–SSX4 gene fusion. The studies we per-
formed demonstrated the presence of SYT–SSX (includ-
ing SYT-SSX1 and/or SYT-SSX2) fusion transcript in all
five cases. Both pathologic and cytogenetic examination
confirmed the diagnosis of PPSS. It was also demon-
strated that RT-PCR with primers using RNA extracted
from the paraffin blocks was feasible, as previously
described [3].
Because of the lack of an established management
protocol, the treatment of SS of the head and neck likely
varies widely at different institutions. The therapeutic
regimen should include surgical extirpation of the tumor
followed by radiationtherapy when appropriate, with or
without adjuvant chemotherapy. Limited excision is
associated with a high incidence of local recurrence (60
to 90%) within two years of the original surgery [8], so
wide local excision to ensure negative margins is the
most important aspect of the treatment. Lymphatic
spread is not a feature of the natural course of thistumor, and there is no established indication for a
prophylactic neck dissection [9]. Use of adjuvant radi-
ation therapy decreases the local recurrence rate [10].
The research by Al-Hussaini indicates that patients with
localized SS have a good chance of cure with surgery
and radiation therapy [11]. A single chemotherapy
protocol has not yet been proven most effective in treat-
ing SS, but two agents, doxorubicin and ifosfamide, have
demonstrated meaningful activity in the treatment of
soft tissue sarcomas [12,13]. So according to the high-
metastatic rate of these tumors, most authors recom-
mend adjuvant chemotherapy as well as postoperative
radiation therapy [2]. In this report, regional or total
neck dissection was performed on two patients, and no
lymph node metastases were found. All five patients
were treated with surgical extirpation of the tumor and
postoperative radiotherapy, and 60% (three of five) of
the patients were alive for more than four years. Two
patients with pulmonary metastasis received additional
chemotherapy. One patient remained disease stable, and
in the other disease progressed and he died of the
disease.
Combined modality therapy of this aggressive tumor
yields better results; however, a five-year survival rate for
these patients is poor and ranges from 25% to 55% [14].
Local or distant failure is seen in approximately 80% of
cases, and lung metastasis is the usual cause of death in
patients with SS of the head and neck [5,15]. Penel et al.
reported that poor prognostic factors of this tumor in-
clude initial metastasis or the presence of lymphadenop-
athy, absence of surgery and number of surgical
procedures [16]. Other studies have shown that tumor
size, histological type, status of surgical margins and
anatomical location also play important roles in predict-
ing local recurrence [17]. The research by Harb WJ et al.
indicates that higher disease-specific and overall survival
rates were associated with upper aero digestive tract lo-
cation, tumors of ≤5 cm, and tumors that did not extend
into the bone [18]. Our follow-up date showed the prog-
nosis of three patients with tumor size <5 cm was better
than the other two patients with tumor size >5 cm. Be-
cause of the rarity of cases, we cannot draw any conclu-
sion by statistical analysis.
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We describe five rare cases of PPSS. Accurate diagnosis
depends on morphologic and immunohistochemical
examination and proper molecular analysis. Like other
sarcomas, definite diagnosis and tumor radical surgical
resection at an early stage remain the mainstay of ther-
apy. Adjuvant therapy, especially radiation, has some
beneficial effect on the overall survival. We have shown
that the prognosis of PPSS is better in those patients
with tumor size less than 5 cm than in the patients with
larger tumors.
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